# Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/bile-duct-obstruction-in-a-patient-treated-with-nivolumab-as-second-line/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jumpei Kashima,Yusuke Okuma,Ryoko Shimizuguchi,Kazuro Chiba |
| Citations | 73 |
| DOI | 10.1007/s00262-017-2062-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/11028312 |
| OpenAlex ID | https://openalex.org/W2754679023 |
| PMID | 28913619 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Jumpei Kashima](https://scholariq.org/researchers/jumpei-kashima/)

## Paper primary topic

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Paper topics

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.